Relationship Between Nucleos(t)ide analogue antiviral response time and prognosis in Chronic Hepatitis B: conclusions depend on baseline viral load and HBeAg status
Antiviral treatment should be adjusted at 48 weeks for non-HVL or HBeAg-negative patients. For HVL and HBeAg-positive patients, we suggest changing the antiviral treatment plan to 96 weeks.
Authors
- Yutian Chong (ORCID: https://orcid.org/0000-0001-8215-4393)
- Xiangyong Li (ORCID: https://orcid.org/0000-0003-1131-5123)
- Hongcui Cao
- Jingtao Huang (ORCID: https://orcid.org/0009-0005-4462-758X)
- Lijie You
Institutions
- Sun Yat-sen University (CN)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-24
- DOI
- https://doi.org/10.3389/fphar.2025.1572827
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00